Warhound Secures $200 Million to Breed Genetically Enhanced Military Canines

A newly unveiled startup is set to transform the U.S. military’s canine workforce by combining genetic engineering with high-tech tactical equipment.

Warhound emerged from stealth on Thursday, revealing a $200 million funding round that values the company at $1.2 billion. The investors include Sequoia, 8VC, Corner Ventures, and In-Q-Tel, a venture firm supported by the CIA and other U.S. intelligence agencies. The venture was conceived by Ben Lamm of Colossal Biosciences and Palmer Luckey of Anduril, who met approximately a year ago at a conference where they discussed the limitations of current military working dogs.

The U.S. currently faces a significant supply challenge, as more than 80 percent of its working dogs are sourced from Europe, and fewer than half of those imports are deemed fit for service. This reliance on foreign nations leaves the military and law enforcement agencies vulnerable. Warhound intends to reverse this trend by engineering dogs with specific traits suited for demanding missions. Lamm noted that many traditional working dogs fail training due to inherited issues such as poor eyesight, cancer risks, hip dysplasia, or muscle atrophy.

The company’s approach involves editing the genes of top-performing breeds, specifically the Belgian Malinois and German Shepherd. By utilizing cell lines stored in a biobank, the team plans to add genes that enhance performance, health, and longevity while removing those that contribute to vulnerabilities. The goal is to create a new type of dog with improved speed, agility, and olfactory sensitivity for tasks like bomb detection. Colossal Biosciences, known for its de-extinction projects, will license its technology to Warhound in exchange for equity.

Anduril will play a critical role by supplying software and hardware, including protection vests and goggles, to assist dogs and their handlers. Lamm described the equipment as a layer of enhancement "on top of the dog, not in the dog," designed to improve situational awareness. For instance, bulletproof vests equipped with data sensors could relay real-time information to handlers, allowing them to better understand the environment and protect both the animal and the human operator.

Luckey is a partner in the venture but does not hold equity, according to Lamm. The first batch of engineered dogs is scheduled to be cloned and incubated shortly, with births expected in early 2027 and potential service entry within two years. Viagen, another entity owned by Colossal, will handle the cloning process, leveraging its technology for a high success rate. While pricing has not been finalized, the company expects to sell to the Department of Defense, police forces, and other first responders.

To address concerns about animal welfare, Warhound is collaborating with the American Humane Society to certify its training programs. The organization stated that it applauds the invitation to participate, citing its foundation in science and ethics. The hope is that retired Warhound dogs will enter the Society’s reunification program to find permanent homes. Lamm assured that each dog will undergo standard military training and be managed by its purchasing agency, ensuring they are treated with the same care as traditional working dogs.